Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Box 534 Uppsala University, 75121 Uppsala, Sweden.
Molecules. 2020 Mar 11;25(6):1277. doi: 10.3390/molecules25061277.
Flufenamic acid (FFA) is a problem drug that has up to eight different polymorphs and shows poor solubility. Variability in bioavailability has been reported in the past resulting in limited use of FFA in the oral solid dosage form. The goal of this article was to investigate the polymorphism and amorphization behavior of FFA in non-heated and heated mixtures with high surface area nanocellulose, i.e., cellulose (CLAD). As a benchmark, low surface area microcrystalline cellulose (MCC) was used. The solid-state properties of mixtures were characterized with X-ray diffraction, Fourier-transform infrared spectroscopy, and differential scanning calorimetry. The dissolution behavior of mixtures was studied in three biorelevant media, i.e., fasted state simulated gastric fluid, fasted state simulated intestinal fluid, and fed state simulated intestinal fluid. Additional thermal analysis and dissolution tests were carried out following 4 months of storage at 75% RH and room temperature. Heated mixtures of FFA with CLAD resulted in complete amorphization of the drug, whereas that with MCC produced a mixture of up to four different polymorphs. The amorphous FFA mixture with CLAD exhibited rapid and invariable fasted/fed state dissolution in simulated intestinal fluids, whereas that of MCC mixtures was highly dependent on the biorelevant medium. The storage of the heated FFA-CLAD mixture did not result in recrystallization or changes in dissolution profile, whereas heated FFA-MCC mixture showed polymorphic changes. The straightforward dry powder formulation strategy presented here bears great promise for reformulating a number of problem drugs to enhance their dissolution properties and reduce the fasted/fed state variability.
氟芬那酸(FFA)是一种存在多种多晶型物且溶解度较差的问题药物。过去曾有报道称,其生物利用度存在变异性,导致 FFA 在口服固体制剂中的应用受到限制。本文的目的是研究 FFA 在未加热和加热状态下与高比表面积纳米纤维素(即纤维素(CLAD))形成的混合物的多晶型和非晶化行为,并以低比表面积微晶纤维素(MCC)作为参比。采用 X 射线衍射、傅里叶变换红外光谱和差示扫描量热法对混合物的固态特性进行了表征。在三种生物相关介质(即空腹模拟胃液、空腹模拟肠液和进食模拟肠液)中研究了混合物的溶解行为。在 75%相对湿度和室温下储存 4 个月后,进行了额外的热分析和溶解试验。加热的 FFA 与 CLAD 形成的混合物导致药物完全非晶化,而与 MCC 形成的混合物则产生多达四种不同的多晶型物。具有 CLAD 的无定形 FFA 混合物在模拟肠液中表现出快速且一致的空腹/进食状态溶解,而 MCC 混合物的溶解则高度依赖于生物相关介质。加热的 FFA-CLAD 混合物的储存并未导致再结晶或溶解曲线发生变化,而加热的 FFA-MCC 混合物则显示出多晶型变化。这里提出的直接干粉制剂策略有望对许多问题药物进行配方改革,以提高其溶解性能并降低空腹/进食状态的变异性。